Our Spin-Off: Genavinta Health

Bridging Translational Research and Real-World Precision Oncology

Genavinta Health is a dynamic Healthtech spin-off emerging from the collaborative efforts of DKFZ and HI-STEM, dedicated to translating cutting-edge genomic and AI-driven precision oncology innovations into accessible, real-world clinical solutions.

Aligned closely with the mission of the GPM group, Genavinta focuses on delivering scalable, data-driven cancer diagnostics and therapies tailored for underrepresented populations, starting with the Asia-Pacific regions including India, Middle East, Singapore & Australia. By bridging advanced translational research with healthcare delivery, Genavinta embodies the social, translational, and global mandates of its founding institutions—bringing precision oncology directly to those who need it most. 

Together, GPM and Genavinta form a powerful partnership that accelerates innovation from the lab bench to the patient bedside, ensuring that scientific breakthroughs translate into meaningful improvements in cancer care worldwide.

   Website: https://genavinta.com